© Borgis - New Medicine 3/2013, s. 91-96
A study assesing the efficiency of treating emotional distress in women with malignant breast tumour
Faculty of Health Sciences, Semmelweis University, Budapest
Head of Faculty: Prof. Dr. Nagy Zoltán Zsolt
Aim. The aim of the study is to examine the change of emotional distress and fatigue influenced by a psychosocial intervention programme in women with non metastatic breast cancer.
Material and methods. The research was carried out in Budapest at the Department of Radiodiagnostics of the National Institute of Oncology. The sample: n=173, (intervention group = 86, control = 87) (34 women have participated in the study), control = 87. The Shortened Beck Depression Inventory, the Spielberger’s State-Trait Anxiety Inventory and the EORTC QLQ C30 quality of life questionnaire have been used for the research.
Results. There was a significant improvement in patients in all three assessed outcome variables. Depression symptoms: F(1.72) = 4.347 p = 0.041; anxiety: F(1.65) = 6.021 p = 0.017; fatigue: F(1.78) = 15.060 p = 0.000.
Conclusions. The early recognition of the presence of anxiety and depression, and their medical and psychological support are crucial. The psychosocial intervention efficiently helped the reduction of emotional distress and fatigue.
According to the 2008 statistics of the World Health Organization, there were 34 million people diagnosed with cancer. There are about 12.5 million registered new cases, and 7.6 million people die of cancer every year around the world. Caring for patients with malignant tumours is causing more and more difficulties for health services. According to John Seffrin, the chief executive officer of the American Cancer Society, cancerous diseases have to be treated as global epidemic (1). By 2030 the number of new cancer patients is estimated to rise to 26 million, and 11.5 million people will die of malignant tumours. In Hungary, during the last 60 years, the number of cancer cases has also gradually risen, and in this respect we are at the top of the statistics among the EU state members (1, 2). Breast cancer is the most common malignant disease in women worldwide. As a result of early recognition and treatment, in the developed countries, including Hungary, the relative 5-year-survival rate is about 80% (1, 3). The diagnosis of breast cancer usually comes as a shock, accompanied by feelings of a threat to life and uncertainty. The state of anxiety and hopelessness has been proved to cause a decline in the health-related quality of life (4). The most common symptoms, such as depression, anxiety and vital exhaustion, can persist for years after the diagnosis (5, 6).
The number of cases affected by clinical anxiety and depression is much smaller, but reserches suggest that the presence of symptoms of subclinical anxiety and depression adversely affects everyday life management and the experience of quality of life. Most authors suggest that the presence of psychological distress is 50%; these are mainly adjustment difficulties accompanied by anxiety and depression. Derogatis found psychological disorders in 47% of the cases (7). In a large sample research (4496 patients), the prevalence of depression showed 52% (8). Hopwood found close correlation between depression and anxiety; 35% of the patients were characterised by this score, and he did not register any significant improvement at the 5-year follow up either (9).
Concerning the subject, only a few studies have been conducted in Hungary.There has been a national representative study carried out by Hungarostudy 2002, surveying the physical and mental health of the adult population of Hungary, and the relationship between health indicators and the environmental, social and economic background. According to their research results, the incidence of clinically significant depression rate in women affected with cancer was 28.5%, while in men it was 27.4% (10). According to the results of a recent study (11), one tenth of women with breast cancer showed depression reaching the clinical border, and nearly two thirds of them had mild depression symptoms. The symptoms of anxiety were shown in one third of the patients, and 20% of these had severe state-trait anxiety. These results confirm the clinical experiences published by Riskó (12), and are also related to the sources of similar studies (13).
Beside distress, one of the most common side-effects of conventional oncology treatments is vital exhaustion, with its defining characteristics: feelings of excessive fatigue and lack of energy and increasing irritability. Normally, there is a strong correlation between these symptoms and depression (14, 6).
Nowadays it is more and more important that the patients are provided with psychological and emotional support, and there is more emphasis put on promoting the ability for spiritual and emotional adjustment, encouraging coping, and improving psychosocial quality of life. During this process, psychosocial interventions have outstanding significance; in complex therapies for cancerous afflictions, the role of onco-psychology and integrated psychosocial care has become increasingly important (15).
The majority of the studies assesing patients with breast-cancer confirms the beneficial effects of psychosocial interventions in reducing emotional distress and also in impoving quality of life (16-20).
MATERIAL AND METHODS
In 2009-2010, a comprehensive psycho-oncology research was conducted, intending to develop a complex, complementary rehabilitation programme in addition to the conventional medical cancer treatment, in order to improve health and quality of life, strengthen coping abilities, and increase the life expectancy of patients suffering from cancer. As first steps of this research, cross-sectional studies were carried out, then a randomized sample was introduced to a complex, psychosocial intervention programme.
Our present study explores the variation of three commonly characteristicsymptoms of breast cancer following a psychosocial intervention programme:
1. Variation of depression and anxiety affected by the programme.
2. Variation of vital exhaustion, fatigue affected by the programme.
The assessed sample and methodologies
173 women agreed to participate in our research, all suffering from malignant breast cancer (C50) and who were currently undergoing medical treatment because of their illness. The research was carried out in Budapest at the Department of Radiodiagnostics of the National Institute of Oncology, with the permission of the Institute’s Ethical Committee. During the assessments an eight-page self-assessment form was used that took 50 minutes to be completed. The sample (n = 173) was randomly divided into treatment (n = 86) and control group (n = 87).Patients assigned to the experimental group were sent a letter of information, followed by telephone contact. 36 patients agreed to participate in the programme. All participants attended the first interview. The 36 patients were divided into two groups; between September and December 2009 (group 1) and between February and June 2010 (group 2). Two patients left the intervention; hence the final number of the participants was 34. Two measurements were carried out: one before the programme (1st measurement – T1) and one after the programme (2nd measurement – T2). The first questionnaires were completed during mammographic investigation, and then the participants received the other packages by post. 51 participants of the control-group (out of 87) returned the questionnaire. Social-demographic characteristics of the sample are shown in table 1.
Table 1. Demographic characteristics of study sample by groups at T1.
| ||Treatment group (N = 36)||Control group (N = 87)||p|
|Age (mean and SD)||53.17 (7.66)||52.09 (9.15)||t = 0.61 ns.|
|Duration of the disease (mean and SD)||2.47 (0.47)||2.55 (0.86)||t = 0.45 ns.|
|Time spent since surgery (mean and SD) ||2.30 (0.74)||2.30 (0.79)||t = 0.04 ns.|
|Education: N (%)|
primary or vocational school
secondary school or higher
p = 0.007*
|Marital status: N (%)|
lack of stable relationship
χ2 = 2.72
|Having Children: N (%)|
χ2 = 2.76
|Economic activity: N (%)|
χ2 = 0.01
|History of family cancer N (%)|
χ2 = 7.16
p < 0.01
SD – Standard Deviation; ns.= non-significant; *Fisher’s exact test
Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Mam kod dostępu
- Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu albo wszystkich artykułów (w zależności od wybranej opcji), należy wprowadzić kod.
- Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.
- Aby kupić kod proszę skorzystać z jednej z poniższych opcji.
- dostęp do tego artykułu
- dostęp na 7 dni
uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony
- dostęp do tego i pozostałych ponad 7000 artykułów
- dostęp na 30 dni
- najpopularniejsza opcja
- dostęp do tego i pozostałych ponad 7000 artykułów
- dostęp na 90 dni
- oszczędzasz 28 zł
1. Tompa A: Daganatos betegségek előfordulása, a hazai és nemzetközi helyzet ismertetése, Global and Hungarian Burden of Cancer. Magyar Tudomány 2011; 11: 1333-1345. 2. WHO 2008. The global burden of disease: 2004 update Geneva: World Health Organization. 3. Coleman MP, Quaresma M, Berrino F et al.: Cancer survival in five continents: a worldwide population-based study (CONCORD). The Lancet Oncology 2008: 9(8): 730-756. doi: 10.1016/s1470-2045(08)70179-7. 4. Fann J: Major depression after breast cancer: a review of epidemiology and treatment. General Hospital Psychiatry 2008;30 (2):112-26. 5. Montazeri A: Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Experim Clinical Cancer Research 2008, 27: 32. doi: 10.1186/1756-9966-27-32 6. Reddick BK, Nanda JP, Campbell L et al.: Examining the influence of coping with pain on depression, anxiety, and fatigue among women with breast cancer. J Psychosocial Oncology 2005; 23(2-3): 137–57. 7. Derogatis LR, Morrow GR, Fetting J et al.: The prevalence of psychiatric disorders among cancer patients. Journal of the American Medical Association 1983; 249: 751-757. 8. Zabora J, Brintzenhofe K, Curbow B et al.: The prevalence of psychological distress by cancer site. Psycho-oncology 2001; 10(1): 19-28. 9. Hopwood P, Sumo G, Mills J et al.: The course of anxiety and depression over 5 years of follow up and risk factors in women with early breast cancer: Results from the UK Standardisation of Radiotherapy Trials (START). Breast 2010; 19(2): 84-91. 10. Dégi L, Csaba: Pszichoszociális kockázati tényezők szerepe a daganatos megbetegedésekben 2008. [In:] Kopp M, Magyar lelkiállapot; Semmelweis Kiadó, Budapest, 557-568. 11. Kovács Zs, Pigniczkiné Rigó A, Hoyer M et al.: The prevalence of depression and anxiety in patients with malignant breast tumour. New Medicine 2011; 15(2): 61-66. 12. Riskó Á: Bevezetés az onkopszichológiába. Animula, Budapest 1999. 13. Reich M, Lesur A, Perdrizet-Chevallier C: Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Research and Treatment 2008; 110(1): 9-17. 14. Silver JK: Rehabilitation in women with breast cancer. Physical Medicine and Rehabilitation Clinics of North America 2007; 18(3): 521-537, doi: 10.1016/j.pmr.2007.05.003. 15. Jacobsen PB, Holland JC, Steensma DP: Caring for the whole patient: the science of psychosocial care. J Clin Oncol 2012; 30: 1151-1153. 16. Fors EA, Bertheussen GF, Thune I et al.: Psychosocial interventions as part of breast cancer rehabilitation programs? Results from a systematic review. Psycho-oncology 2011; 20(9): 909-918, doi: 10.1002/pon.1844. 17. Kissane D: Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psycho-oncology 2009; 18(1): 1-5, doi: 10.1002/pon.1493. 18. Naaman SC, Radwan K, Fergusson D, Johnson S: Status of psychological trials in breast cancer patients: a report of three meta-analyses. Psychiatry 2009; 72(1): 50-69, doi: 10.1521/psyc.2009.72.1.50. 19. Osborn RL, Demoncada AC, Feuerstein M: Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatr Med 2006; 36: 13-34. 20. Dewey A: Psychosocial interventions for reducing fatigue during cancer treatment in adults. Int J Evid Based Health 2010; 8: 106-107. 21. Beck AT, Beck RW: Screening depressed patient in family practice. A rapid technic. Postgrad Med 1972; 52: 81-85. 22. Rózsa S, Szádóczky E, Füredi J: A Beck Depresszió Kérdôív rövidített változatának jellemzôi hazai mintán. Psychiatria Hungarica 2001; 16: 384-402. 23. Spielberger CD, Gorsuch RL, Lushene RE: Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press 1970, Palo Alto, CA. 24. Sipos K, Sipos M, Spielberger CD: A State-Trait Anxiety Inventory (STAI) magyar változata. [In:] Mérei F, Szakács F (red.): Pszichodiagnosztikai vademecum I/2. Nemzeti Tankönyvkiadó, Budapest 1994, 123-148. 25. Aaronson NK, Ahmedzai S, Bergman B et al.: The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. Journal of National Cancer Institute 1993; 85: 365-367. 26. Dégi LC: Onkopszichológiai beavatkozások hatékonyságvizsgálata a daganatos betegek életminősége és túlélési esélye szempontjából. Psychiatr Hung 2006; 21: 138-146. 27. Greer S: Psychological intervention. The gap between research and practice. Acta Oncol 2002; 41: 238-243.